Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells

Hong Yang, Lisa Kozicky, Aabida Saferali, Shan Yu Fung, Nicole Afacan, Bing Cai, Reza Falsafi, Erin Gill, Mingyao Liu, Tobias R. Kollmann, Robert Hancock, Laura M. Sly, Stuart E. Turvey

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Toll-like receptor (TLR) signaling plays a central role in the pathophysiology of many acute and chronic human inflammatory diseases, and pharmacological regulation of TLR responses is anticipated to be beneficial in many inflammatory conditions. Currently there are no specific TLR inhibitors in clinical use. To overcome this challenge, we have developed a nano-based TLR inhibitor (peptide-gold nanoparticle hybrids) that inhibits a broad spectrum of TLR responses. Through mechanistic studies, we established that specific peptide decorated-gold nanoparticles that display high cellular uptake in phagocytic immune cells modulate endosomal pH, leading to significant attenuation of signaling through multiple TLRs. Using a global transcriptomic approach, we defined the broad anti-inflammatory activity of the nanoparticle in human peripheral blood mononuclear cells. In vivo studies confirmed the beneficial immunomodulatory activity since treatment with the nanoparticle significantly reduced weight loss, improved the disease activity index, and ameliorated colonic inflammation in a murine model of intestinal inflammation. This work enhances our fundamental understanding of the role of peptide coatings on the nanoparticle surface in regulating innate immune signaling, and identifies specific peptide decorated nanoparticles that may represent a novel class of anti-inflammatory therapeutics for human inflammatory diseases.

LanguageEnglish
Pages90-102
Number of pages13
JournalBiomaterials
Volume111
DOIs
Publication statusPublished - 1 Dec 2016

Keywords

  • Anti-inflammatory therapeutics
  • Immune modulation
  • Inflammatory bowel disease
  • Nanoparticle
  • Peptide-conjugation
  • Toll-like receptor signaling

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Yang, Hong ; Kozicky, Lisa ; Saferali, Aabida ; Fung, Shan Yu ; Afacan, Nicole ; Cai, Bing ; Falsafi, Reza ; Gill, Erin ; Liu, Mingyao ; Kollmann, Tobias R. ; Hancock, Robert ; Sly, Laura M. ; Turvey, Stuart E. / Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. In: Biomaterials. 2016 ; Vol. 111. pp. 90-102.
@article{39992daf328a42dda489f117c2ac473d,
title = "Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells",
abstract = "Toll-like receptor (TLR) signaling plays a central role in the pathophysiology of many acute and chronic human inflammatory diseases, and pharmacological regulation of TLR responses is anticipated to be beneficial in many inflammatory conditions. Currently there are no specific TLR inhibitors in clinical use. To overcome this challenge, we have developed a nano-based TLR inhibitor (peptide-gold nanoparticle hybrids) that inhibits a broad spectrum of TLR responses. Through mechanistic studies, we established that specific peptide decorated-gold nanoparticles that display high cellular uptake in phagocytic immune cells modulate endosomal pH, leading to significant attenuation of signaling through multiple TLRs. Using a global transcriptomic approach, we defined the broad anti-inflammatory activity of the nanoparticle in human peripheral blood mononuclear cells. In vivo studies confirmed the beneficial immunomodulatory activity since treatment with the nanoparticle significantly reduced weight loss, improved the disease activity index, and ameliorated colonic inflammation in a murine model of intestinal inflammation. This work enhances our fundamental understanding of the role of peptide coatings on the nanoparticle surface in regulating innate immune signaling, and identifies specific peptide decorated nanoparticles that may represent a novel class of anti-inflammatory therapeutics for human inflammatory diseases.",
keywords = "Anti-inflammatory therapeutics, Immune modulation, Inflammatory bowel disease, Nanoparticle, Peptide-conjugation, Toll-like receptor signaling",
author = "Hong Yang and Lisa Kozicky and Aabida Saferali and Fung, {Shan Yu} and Nicole Afacan and Bing Cai and Reza Falsafi and Erin Gill and Mingyao Liu and Kollmann, {Tobias R.} and Robert Hancock and Sly, {Laura M.} and Turvey, {Stuart E.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.biomaterials.2016.09.032",
language = "English",
volume = "111",
pages = "90--102",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

Yang, H, Kozicky, L, Saferali, A, Fung, SY, Afacan, N, Cai, B, Falsafi, R, Gill, E, Liu, M, Kollmann, TR, Hancock, R, Sly, LM & Turvey, SE 2016, 'Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells', Biomaterials, vol. 111, pp. 90-102. https://doi.org/10.1016/j.biomaterials.2016.09.032

Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. / Yang, Hong; Kozicky, Lisa; Saferali, Aabida; Fung, Shan Yu; Afacan, Nicole; Cai, Bing; Falsafi, Reza; Gill, Erin; Liu, Mingyao; Kollmann, Tobias R.; Hancock, Robert; Sly, Laura M.; Turvey, Stuart E.

In: Biomaterials, Vol. 111, 01.12.2016, p. 90-102.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells

AU - Yang, Hong

AU - Kozicky, Lisa

AU - Saferali, Aabida

AU - Fung, Shan Yu

AU - Afacan, Nicole

AU - Cai, Bing

AU - Falsafi, Reza

AU - Gill, Erin

AU - Liu, Mingyao

AU - Kollmann, Tobias R.

AU - Hancock, Robert

AU - Sly, Laura M.

AU - Turvey, Stuart E.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Toll-like receptor (TLR) signaling plays a central role in the pathophysiology of many acute and chronic human inflammatory diseases, and pharmacological regulation of TLR responses is anticipated to be beneficial in many inflammatory conditions. Currently there are no specific TLR inhibitors in clinical use. To overcome this challenge, we have developed a nano-based TLR inhibitor (peptide-gold nanoparticle hybrids) that inhibits a broad spectrum of TLR responses. Through mechanistic studies, we established that specific peptide decorated-gold nanoparticles that display high cellular uptake in phagocytic immune cells modulate endosomal pH, leading to significant attenuation of signaling through multiple TLRs. Using a global transcriptomic approach, we defined the broad anti-inflammatory activity of the nanoparticle in human peripheral blood mononuclear cells. In vivo studies confirmed the beneficial immunomodulatory activity since treatment with the nanoparticle significantly reduced weight loss, improved the disease activity index, and ameliorated colonic inflammation in a murine model of intestinal inflammation. This work enhances our fundamental understanding of the role of peptide coatings on the nanoparticle surface in regulating innate immune signaling, and identifies specific peptide decorated nanoparticles that may represent a novel class of anti-inflammatory therapeutics for human inflammatory diseases.

AB - Toll-like receptor (TLR) signaling plays a central role in the pathophysiology of many acute and chronic human inflammatory diseases, and pharmacological regulation of TLR responses is anticipated to be beneficial in many inflammatory conditions. Currently there are no specific TLR inhibitors in clinical use. To overcome this challenge, we have developed a nano-based TLR inhibitor (peptide-gold nanoparticle hybrids) that inhibits a broad spectrum of TLR responses. Through mechanistic studies, we established that specific peptide decorated-gold nanoparticles that display high cellular uptake in phagocytic immune cells modulate endosomal pH, leading to significant attenuation of signaling through multiple TLRs. Using a global transcriptomic approach, we defined the broad anti-inflammatory activity of the nanoparticle in human peripheral blood mononuclear cells. In vivo studies confirmed the beneficial immunomodulatory activity since treatment with the nanoparticle significantly reduced weight loss, improved the disease activity index, and ameliorated colonic inflammation in a murine model of intestinal inflammation. This work enhances our fundamental understanding of the role of peptide coatings on the nanoparticle surface in regulating innate immune signaling, and identifies specific peptide decorated nanoparticles that may represent a novel class of anti-inflammatory therapeutics for human inflammatory diseases.

KW - Anti-inflammatory therapeutics

KW - Immune modulation

KW - Inflammatory bowel disease

KW - Nanoparticle

KW - Peptide-conjugation

KW - Toll-like receptor signaling

UR - http://www.scopus.com/inward/record.url?scp=84991105240&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2016.09.032

DO - 10.1016/j.biomaterials.2016.09.032

M3 - Article

VL - 111

SP - 90

EP - 102

JO - Biomaterials

T2 - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -